Cargando…

A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting

BACKGROUND: Postoperative bleeding in patients who underwent elective coronary artery bypass surgery (CABG) may increase due to preoperative anticoagulant therapy indicative of their disease - acute coronary syndrome or implanted coronary artery stent. Increased bleeding in many cases requires the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Straus, Slavenka, Haxhibeqiri-Karabdic, Ilirijana, Grabovica, Sanja Granov, Granov, Nermir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789565/
https://www.ncbi.nlm.nih.gov/pubmed/29416215
http://dx.doi.org/10.5455/medarh.2018.72.31-35
_version_ 1783296304361766912
author Straus, Slavenka
Haxhibeqiri-Karabdic, Ilirijana
Grabovica, Sanja Granov
Granov, Nermir
author_facet Straus, Slavenka
Haxhibeqiri-Karabdic, Ilirijana
Grabovica, Sanja Granov
Granov, Nermir
author_sort Straus, Slavenka
collection PubMed
description BACKGROUND: Postoperative bleeding in patients who underwent elective coronary artery bypass surgery (CABG) may increase due to preoperative anticoagulant therapy indicative of their disease - acute coronary syndrome or implanted coronary artery stent. Increased bleeding in many cases requires the use of blood and blood derivatives, and sometimes even reoperation. Their use poses the risk of complications, may extend the hospitalization. METHODS: Our observation retrospective study included 131 patients, 41 treated with aspirin and 90 treated with aspirin and clopidogrel. All underwent for the first time elective on-pump isolated CABG surgery at Clinic for cardiovascular surgery of Clinical Center University of Sarajevo, in period June 2016 to September 2017. The data were collected from patient’s records. RESULTS: Out of 131 patients,73.3% were male. The average age was 62. The average total drainage during the first 48 postoperative hours in ASA group was 1027.4±404.9ml and 1049.8±371.3ml in DAPT group. The mean number of whole blood transfusions in the DAPT group washigher compared to ASAgroup. The average number of fresh frozen plasma were higher in the DAPT group 0.84±0.51 compared to the group ASA 0.39±0.07, as well the average thrombocytes transfusions were slightly higher in the DAPT group. Statistical analysis suggests that there is no significant difference between the observed groups (p>0.05). Also, our study did not show a statistically significant difference between arrhythmia onset, the length of mechanical ventilation, use of protamineand tranexamic acid. Reoperation due to postoperative bleeding was recorded in 2 cases in the DAPT group as well as 2 lethal cases. CONCLUSION: In our study, we could not demonstrate less postoperative bleeding and use of blood and blood products in a group of patients who were preoperatively treated with aspirin compared to patients with dual antiplatelet therapy in the elective isolated CABG surgery.
format Online
Article
Text
id pubmed-5789565
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Academy of Medical Sciences of Bosnia and Herzegovina
record_format MEDLINE/PubMed
spelling pubmed-57895652018-02-08 A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting Straus, Slavenka Haxhibeqiri-Karabdic, Ilirijana Grabovica, Sanja Granov Granov, Nermir Med Arch Original Paper BACKGROUND: Postoperative bleeding in patients who underwent elective coronary artery bypass surgery (CABG) may increase due to preoperative anticoagulant therapy indicative of their disease - acute coronary syndrome or implanted coronary artery stent. Increased bleeding in many cases requires the use of blood and blood derivatives, and sometimes even reoperation. Their use poses the risk of complications, may extend the hospitalization. METHODS: Our observation retrospective study included 131 patients, 41 treated with aspirin and 90 treated with aspirin and clopidogrel. All underwent for the first time elective on-pump isolated CABG surgery at Clinic for cardiovascular surgery of Clinical Center University of Sarajevo, in period June 2016 to September 2017. The data were collected from patient’s records. RESULTS: Out of 131 patients,73.3% were male. The average age was 62. The average total drainage during the first 48 postoperative hours in ASA group was 1027.4±404.9ml and 1049.8±371.3ml in DAPT group. The mean number of whole blood transfusions in the DAPT group washigher compared to ASAgroup. The average number of fresh frozen plasma were higher in the DAPT group 0.84±0.51 compared to the group ASA 0.39±0.07, as well the average thrombocytes transfusions were slightly higher in the DAPT group. Statistical analysis suggests that there is no significant difference between the observed groups (p>0.05). Also, our study did not show a statistically significant difference between arrhythmia onset, the length of mechanical ventilation, use of protamineand tranexamic acid. Reoperation due to postoperative bleeding was recorded in 2 cases in the DAPT group as well as 2 lethal cases. CONCLUSION: In our study, we could not demonstrate less postoperative bleeding and use of blood and blood products in a group of patients who were preoperatively treated with aspirin compared to patients with dual antiplatelet therapy in the elective isolated CABG surgery. Academy of Medical Sciences of Bosnia and Herzegovina 2018-02 /pmc/articles/PMC5789565/ /pubmed/29416215 http://dx.doi.org/10.5455/medarh.2018.72.31-35 Text en © 2018 Slavenka Straus, Ilirijana Haxhibeqiri-Karabdic, Sanja Granov Grabovica, Nermir Granov http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Straus, Slavenka
Haxhibeqiri-Karabdic, Ilirijana
Grabovica, Sanja Granov
Granov, Nermir
A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting
title A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting
title_full A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting
title_fullStr A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting
title_full_unstemmed A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting
title_short A Difference in Bleeding and Use of Blood and Blood Products in Patients who Were Preoperatively on Aspirin or Dual Antiplatelet Therapy Before Coronary Artery Bypass Grafting
title_sort difference in bleeding and use of blood and blood products in patients who were preoperatively on aspirin or dual antiplatelet therapy before coronary artery bypass grafting
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789565/
https://www.ncbi.nlm.nih.gov/pubmed/29416215
http://dx.doi.org/10.5455/medarh.2018.72.31-35
work_keys_str_mv AT strausslavenka adifferenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting
AT haxhibeqirikarabdicilirijana adifferenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting
AT grabovicasanjagranov adifferenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting
AT granovnermir adifferenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting
AT strausslavenka differenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting
AT haxhibeqirikarabdicilirijana differenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting
AT grabovicasanjagranov differenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting
AT granovnermir differenceinbleedinganduseofbloodandbloodproductsinpatientswhowerepreoperativelyonaspirinordualantiplatelettherapybeforecoronaryarterybypassgrafting